Benjamin Pradere

407 total citations · 1 hit paper
17 papers, 78 citations indexed

About

Benjamin Pradere is a scholar working on Surgery, Urology and Infectious Diseases. According to data from OpenAlex, Benjamin Pradere has authored 17 papers receiving a total of 78 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 6 papers in Urology and 2 papers in Infectious Diseases. Recurrent topics in Benjamin Pradere's work include Bladder and Urothelial Cancer Treatments (17 papers), Urinary and Genital Oncology Studies (13 papers) and Urological Disorders and Treatments (6 papers). Benjamin Pradere is often cited by papers focused on Bladder and Urothelial Cancer Treatments (17 papers), Urinary and Genital Oncology Studies (13 papers) and Urological Disorders and Treatments (6 papers). Benjamin Pradere collaborates with scholars based in France, Italy and United States. Benjamin Pradere's co-authors include Bas W.G. van Rhijn, Fredrik Liedberg, Évanguelos Xylinas, Otakar Čapoun, Bhavan Prasad, Francesco Soria, Paramananthan Mariappan, Robert E. Wood, Hugh Mostafid and Alison Birtle and has published in prestigious journals such as The Lancet Oncology, European Urology and British Journal of Urology.

In The Last Decade

Benjamin Pradere

12 papers receiving 78 citations

Hit Papers

European Association of Urology Guidelines on Non–muscle-... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
    2024 54 citations Paolo Gontero, Alison Birtle et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Pradere France 3 67 19 10 10 8 17 78
C Tanabalan United Kingdom 2 36 0.5× 21 1.1× 13 1.3× 11 1.1× 9 1.1× 6 61
Pravin Viswambaram Australia 4 36 0.5× 13 0.7× 15 1.5× 15 1.5× 16 2.0× 17 63
Arne Tiemann Germany 4 53 0.8× 5 0.3× 19 1.9× 8 0.8× 11 1.4× 4 61
Miodrag Lazić Serbia 4 15 0.2× 12 0.6× 12 1.2× 9 0.9× 21 2.6× 19 48
M Assumma Italy 2 44 0.7× 30 1.6× 5 0.5× 4 0.4× 23 2.9× 3 69
William P. Duggan Ireland 5 23 0.3× 19 1.0× 2 0.2× 19 1.9× 7 0.9× 24 64
Albert Font Pous Spain 5 104 1.6× 11 0.6× 18 1.8× 74 7.4× 20 2.5× 18 122
Maly Fenelus United States 4 26 0.4× 22 1.2× 8 0.8× 24 2.4× 2 0.3× 11 58
Kathryn O’Shea United Kingdom 5 20 0.3× 11 0.6× 2 0.2× 5 0.5× 10 1.3× 12 43
Christa Freibauer Austria 4 17 0.3× 21 1.1× 5 0.5× 10 1.0× 31 3.9× 5 56

Countries citing papers authored by Benjamin Pradere

Since Specialization
Citations

This map shows the geographic impact of Benjamin Pradere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Pradere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Pradere more than expected).

Fields of papers citing papers by Benjamin Pradere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Pradere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Pradere. The network helps show where Benjamin Pradere may publish in the future.

Co-authorship network of co-authors of Benjamin Pradere

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Pradere. A scholar is included among the top collaborators of Benjamin Pradere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Pradere. Benjamin Pradere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
4.
Yanagisawa, Takafumi, Akihiro Matsukawa, Jeremy Yuen‐Chun Teoh, et al.. (2025). Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updates. Bladder Cancer. 11(2). 1802647506–1802647506. 1 indexed citations
5.
Guerrero‐Ramos, Félix, et al.. (2025). Hyperthermic intravesical chemotherapy for Bacillus Calmette–Guérin-unresponsive nonmuscle-invasive bladder cancer. Current Opinion in Urology. 35(6). 620–628. 1 indexed citations
6.
7.
Schiavone, Nicola, Biagio Barone, Roberto Contieri, et al.. (2025). Refining Active Surveillance Eligibility in Intermediate-risk Non–muscle-invasive Bladder Cancer: The Impact of Time to First Recurrence. European Urology Open Science. 82. 155–159.
8.
Khene, Z., et al.. (2025). Novel intravesical delivery systems for nonmuscle invasive bladder cancer. Current Opinion in Urology. 35(6). 645–652.
9.
Yanagisawa, Takafumi, Keiichiro Mori, Akihiro Matsukawa, et al.. (2025). Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis. Cancer Immunology Immunotherapy. 74(3). 76–76. 1 indexed citations
10.
Moretto, Stefano, Roberto Contieri, Alessandro Uleri, et al.. (2025). The role of primary tumour site surgery in metastatic UTUC : a systematic review and meta‐analysis. British Journal of Urology. 136(4). 602–611. 1 indexed citations
11.
Ouzaïd, Idir, Benjamin Pradere, M. Roumiguié, et al.. (2025). Emerging evidence of immunotherapy in BCG-unresponsive non-muscle invasive bladder cancer. 37(3). 1 indexed citations
12.
Gontero, Paolo, Alison Birtle, Otakar Čapoun, et al.. (2024). European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update. European Urology. 86(6). 531–549. 54 indexed citations breakdown →
13.
Basile, Giuseppe, Riccardo Leni, Donato Cannoletta, et al.. (2024). En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Systematic Review and Meta-analysis of Oncological, Histopathological, and Surgical Outcomes. European Urology Oncology. 8(2). 520–533. 2 indexed citations
14.
Li, Roger, James W.F. Catto, Siamak Daneshmand, et al.. (2024). FGFR Inhibition in Urothelial Carcinoma. European Urology. 87(2). 110–122. 12 indexed citations
15.
Moretto, Stefano, Andrea Gallioli, Roberto Contieri, et al.. (2024). The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis. Urologic Oncology Seminars and Original Investigations. 43(3). 191.e1–191.e12. 2 indexed citations
16.
Calleris, Giorgio, Markus von Deimling, Claudia Kesch, et al.. (2024). Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology. Current Opinion in Urology. 34(3). 217–224.
17.
Rahman, Syed N., Soum D. Lokeshwar, Jamil Syed, et al.. (2022). Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 41(2). 107.e1–107.e8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Tanabalan Breakdown of academic impact, for papers by Pravin Viswambaram Breakdown of academic impact, for papers by Arne Tiemann Breakdown of academic impact, for papers by Miodrag Lazić Breakdown of academic impact, for papers by M Assumma Breakdown of academic impact, for papers by William P. Duggan Breakdown of academic impact, for papers by Albert Font Pous Breakdown of academic impact, for papers by Maly Fenelus Breakdown of academic impact, for papers by Kathryn O’Shea Breakdown of academic impact, for papers by Christa Freibauer
Rankless by CCL
2026